MEP42508A - Inhalation capsules - Google Patents
Inhalation capsulesInfo
- Publication number
- MEP42508A MEP42508A MEP-425/08A MEP42508A MEP42508A ME P42508 A MEP42508 A ME P42508A ME P42508 A MEP42508 A ME P42508A ME P42508 A MEP42508 A ME P42508A
- Authority
- ME
- Montenegro
- Prior art keywords
- inhalation capsules
- inhalation
- capsules
- inhalers
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
- A61M11/003—Particle size control by passing the aerosol trough sieves or filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Pronalazak se odnosi na inhalacione kapsule (inhalete) načinjene od specifičnog materijala za kapsule, sa smanjenim sadržajem vlage, koje kao djelotvornu supstancu sadrže tiotropijum, u obliku preparata u prahu, za koje je karakteristična povećana stabilnost.The invention relates to inhalation capsules (inhalers) made of a specific capsule material, with reduced moisture content, containing tiotropium as an active ingredient in powder form, characterized by increased stability.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10126924A DE10126924A1 (en) | 2001-06-01 | 2001-06-01 | Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability |
PCT/EP2002/005600 WO2002098874A2 (en) | 2001-06-01 | 2002-05-27 | Inhalation capsules |
Publications (2)
Publication Number | Publication Date |
---|---|
MEP42508A true MEP42508A (en) | 2011-02-10 |
ME00301B ME00301B (en) | 2011-05-10 |
Family
ID=7687020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-2008-425A ME00301B (en) | 2001-06-01 | 2002-05-27 | Inhalation capsules |
Country Status (37)
Country | Link |
---|---|
EP (2) | EP1508330A1 (en) |
JP (3) | JP4447311B2 (en) |
KR (2) | KR100952321B1 (en) |
CN (3) | CN1512875A (en) |
AR (2) | AR034346A1 (en) |
AT (1) | ATE285752T1 (en) |
AU (2) | AU2002344354B2 (en) |
BG (1) | BG65655B1 (en) |
BR (1) | BR0209366A (en) |
CA (1) | CA2448425C (en) |
CH (1) | CH1379220H1 (en) |
CO (1) | CO5540379A2 (en) |
CZ (1) | CZ300284B6 (en) |
DE (2) | DE10126924A1 (en) |
EA (1) | EA005188B1 (en) |
EC (2) | ECSP034868A (en) |
EE (1) | EE05416B1 (en) |
EG (1) | EG24227A (en) |
ES (1) | ES2236590B5 (en) |
HR (1) | HRP20030993B1 (en) |
HU (3) | HU230827B1 (en) |
IL (2) | IL158917A0 (en) |
ME (1) | ME00301B (en) |
MX (1) | MXPA03010990A (en) |
MY (1) | MY126253A (en) |
NO (1) | NO332857B3 (en) |
NZ (1) | NZ530356A (en) |
PE (1) | PE20030071A1 (en) |
PL (2) | PL205714B1 (en) |
PT (1) | PT1379220E (en) |
RS (1) | RS50353B (en) |
SI (1) | SI1379220T1 (en) |
SK (2) | SK287379B6 (en) |
TW (1) | TWI327921B (en) |
UA (1) | UA75659C2 (en) |
WO (1) | WO2002098874A2 (en) |
ZA (1) | ZA200308340B (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA72014C2 (en) | 2000-10-12 | 2005-01-17 | Boehringer Ingelheim Pharma | Tiotropium-containing powdery preparations for inhalations intended for treating asthma and chronic obstructive pulmonary disease (variants), method for their production and capsule |
DE10126924A1 (en) * | 2001-06-01 | 2002-12-05 | Boehringer Ingelheim Pharma | Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability |
DE10212264A1 (en) | 2002-03-20 | 2003-10-02 | Boehringer Ingelheim Pharma | Crystalline micronisate, process for its preparation and its use for the manufacture of a medicament |
WO2003094890A1 (en) * | 2002-05-07 | 2003-11-20 | Nektar Therapeutics | Capsules for dry powder inhalers and methods of making and using same |
US7763280B2 (en) | 2002-11-28 | 2010-07-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing powder formulation for inhalation |
DE10255387A1 (en) * | 2002-11-28 | 2004-06-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New tiotropium-containing powder formulation for inhalation |
DE10258360A1 (en) * | 2002-12-12 | 2004-06-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Chamber for accommodation of disposable capsules for powder inhalers has an inner surface with protruding elements serving as distance pieces between the capsules |
DE10352277A1 (en) * | 2003-11-08 | 2005-06-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | powder inhaler |
SE0303570L (en) | 2003-12-03 | 2005-06-04 | Microdrug Ag | Moisture-sensitive medical product |
SE0303269L (en) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Medical product |
GB0503738D0 (en) | 2005-02-23 | 2005-03-30 | Optinose As | Powder delivery devices |
US7694676B2 (en) | 2005-04-22 | 2010-04-13 | Boehringer Ingelheim Gmbh | Dry powder inhaler |
JP4825455B2 (en) * | 2005-05-02 | 2011-11-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Powder inhaler |
DE102006016901A1 (en) * | 2006-04-11 | 2007-10-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Mouthpiece for an inhaler |
DE102006016904A1 (en) | 2006-04-11 | 2007-10-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | inhaler |
GB0716026D0 (en) | 2007-08-16 | 2007-09-26 | Norton Healthcare Ltd | An inhalable medicament |
DE102007036411A1 (en) | 2007-07-20 | 2009-02-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | powder inhaler |
DE102007052871A1 (en) * | 2007-11-02 | 2009-05-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Capsule for receiving pharmaceutical drug formulations |
EP2244686A1 (en) * | 2008-02-08 | 2010-11-03 | Boehringer Ingelheim International GmbH | Method and device for filling capsules |
EP2172190A1 (en) * | 2008-10-02 | 2010-04-07 | Laboratorios Liconsa, S.A. | Inhalable particles comprising tiotropium |
EP4403231A2 (en) | 2009-02-26 | 2024-07-24 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
WO2010110760A1 (en) * | 2009-03-27 | 2010-09-30 | Mahmut Bilgic | Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
US9259376B2 (en) | 2010-06-03 | 2016-02-16 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. | Process for dry powder formulations |
DE202011102694U1 (en) | 2011-06-29 | 2011-12-19 | Zisser Gmbh | Inhaler for home users |
GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
US20150150802A1 (en) | 2012-07-05 | 2015-06-04 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhaler compositions comprising long acting muscarinic antagonists |
DE202013000774U1 (en) | 2013-01-21 | 2013-04-15 | Rhinofilt GmbH | Miniaturized inhalation device for home use |
US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
CN108295042A (en) * | 2018-03-05 | 2018-07-20 | 上海祺宇生物科技有限公司 | A kind of plant hollow capsule and its capsule for sucking medicament |
CN108451920A (en) * | 2018-03-14 | 2018-08-28 | 绍兴康可胶囊有限公司 | A kind of suction mist formula capsule and preparation method thereof |
CN114848605B (en) * | 2022-03-25 | 2023-08-11 | 上海方予健康医药科技有限公司 | Gelatin capsule for inhalation of powder fog agent |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3931041C2 (en) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them |
CA2115444C (en) * | 1992-06-12 | 2000-10-03 | Yuji Makino | Preparation for intratracheobronchial administration |
US6228394B1 (en) * | 1997-10-14 | 2001-05-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | Supercritical fluid extraction of mould lubricant from hard shell capsules |
DE19835346A1 (en) * | 1998-08-05 | 2000-02-10 | Boehringer Ingelheim Pharma | Two-part capsule for pharmaceutical preparations for powder inhalers |
JP2000143502A (en) * | 1998-11-11 | 2000-05-23 | Shionogi Qualicaps Kk | Inhalant preparation |
EP1283036B2 (en) * | 1998-11-13 | 2020-01-01 | Jagotec AG | Dry powder for inhalation |
DE19921693A1 (en) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects |
EP1072258A1 (en) * | 1999-07-28 | 2001-01-31 | Greither, Peter | Capsule for the release of bacteria, containing lyophilised bacteria and a method for the production thereof |
AU7685200A (en) * | 1999-10-12 | 2001-04-23 | Kaken Pharmaceutical Co., Ltd. | Powdery inhalational preparations and process for producing the same |
DE10126924A1 (en) * | 2001-06-01 | 2002-12-05 | Boehringer Ingelheim Pharma | Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability |
-
2001
- 2001-06-01 DE DE10126924A patent/DE10126924A1/en not_active Withdrawn
-
2002
- 2002-05-27 JP JP2003501995A patent/JP4447311B2/en not_active Expired - Lifetime
- 2002-05-27 WO PCT/EP2002/005600 patent/WO2002098874A2/en active Application Filing
- 2002-05-27 EE EEP200300595A patent/EE05416B1/en unknown
- 2002-05-27 ES ES02776507.2T patent/ES2236590B5/en not_active Expired - Lifetime
- 2002-05-27 SI SI200230077T patent/SI1379220T1/en unknown
- 2002-05-27 HU HU1500188A patent/HU230827B1/en unknown
- 2002-05-27 CH CH02776507T patent/CH1379220H1/de unknown
- 2002-05-27 CZ CZ20033579A patent/CZ300284B6/en not_active IP Right Cessation
- 2002-05-27 CN CNA028109791A patent/CN1512875A/en active Pending
- 2002-05-27 SK SK1620-2003A patent/SK287379B6/en not_active IP Right Cessation
- 2002-05-27 EP EP04026411A patent/EP1508330A1/en not_active Withdrawn
- 2002-05-27 PL PL387118A patent/PL205714B1/en unknown
- 2002-05-27 SK SK50049-2009A patent/SK287346B6/en not_active IP Right Cessation
- 2002-05-27 EA EA200301275A patent/EA005188B1/en not_active IP Right Cessation
- 2002-05-27 DE DE50201898T patent/DE50201898D1/en not_active Expired - Lifetime
- 2002-05-27 PT PT02776507T patent/PT1379220E/en unknown
- 2002-05-27 ME MEP-2008-425A patent/ME00301B/en unknown
- 2002-05-27 KR KR1020097000835A patent/KR100952321B1/en active IP Right Review Request
- 2002-05-27 BR BR0209366-9A patent/BR0209366A/en active Pending
- 2002-05-27 UA UA20031212504A patent/UA75659C2/en unknown
- 2002-05-27 EP EP02776507A patent/EP1379220B1/en not_active Expired - Lifetime
- 2002-05-27 AU AU2002344354A patent/AU2002344354B2/en not_active Expired
- 2002-05-27 CN CN200910149591A patent/CN101697965A/en active Pending
- 2002-05-27 PL PL364108A patent/PL203801B1/en unknown
- 2002-05-27 HU HU1800092A patent/HU231082B1/en unknown
- 2002-05-27 IL IL15891702A patent/IL158917A0/en unknown
- 2002-05-27 CN CN201010143914A patent/CN101829072A/en active Pending
- 2002-05-27 NZ NZ530356A patent/NZ530356A/en not_active IP Right Cessation
- 2002-05-27 MX MXPA03010990A patent/MXPA03010990A/en active IP Right Grant
- 2002-05-27 HU HU0400666A patent/HU230058B1/en not_active IP Right Cessation
- 2002-05-27 AT AT02776507T patent/ATE285752T1/en active
- 2002-05-27 CA CA2448425A patent/CA2448425C/en not_active Expired - Fee Related
- 2002-05-27 RS YUP-935/03A patent/RS50353B/en unknown
- 2002-05-27 KR KR1020037015718A patent/KR100921904B1/en active IP Right Grant
- 2002-05-29 EG EG20020570A patent/EG24227A/en active
- 2002-05-29 AR ARP020102000A patent/AR034346A1/en not_active Ceased/Invalidation/Refusal/Rejection/Nullification
- 2002-05-31 TW TW091111706A patent/TWI327921B/en not_active IP Right Cessation
- 2002-05-31 PE PE2002000465A patent/PE20030071A1/en active IP Right Grant
- 2002-05-31 MY MYPI20022036A patent/MY126253A/en unknown
-
2003
- 2003-10-27 ZA ZA200308340A patent/ZA200308340B/en unknown
- 2003-11-18 IL IL158917A patent/IL158917A/en active IP Right Grant
- 2003-11-24 BG BG108380A patent/BG65655B1/en active Active
- 2003-11-27 EC EC2003004868A patent/ECSP034868A/en unknown
- 2003-11-27 NO NO20035265A patent/NO332857B3/en not_active IP Right Cessation
- 2003-11-28 HR HR20030993A patent/HRP20030993B1/en not_active IP Right Cessation
- 2003-12-10 CO CO03108303A patent/CO5540379A2/en not_active Application Discontinuation
-
2006
- 2006-02-15 JP JP2006038063A patent/JP4787034B2/en not_active Expired - Lifetime
-
2007
- 2007-10-03 JP JP2007260177A patent/JP2008050364A/en active Pending
-
2008
- 2008-07-10 AU AU2008203057A patent/AU2008203057C1/en not_active Expired
-
2011
- 2011-01-06 EC EC2011004868A patent/ECSP11004868A/en unknown
-
2012
- 2012-01-06 AR ARP120100053A patent/AR084804A2/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MEP42508A (en) | Inhalation capsules | |
MX2007013878A (en) | Inhalator capsules. | |
HRP20040933B1 (en) | Inhalation kit comprisung inhalable powder of tiotropium | |
ECSP024268A (en) | NEW POWDER FOR INHALATION CONTAINING TIOTROPY | |
ID28290A (en) | CAPSULE TWO PARTS TO STORE PHARMACEUTICAL PROPERTIES FOR POWDER INHALERS | |
NO20015082L (en) | Powder inhalation device for combined drug | |
MXPA05001621A (en) | Improvements in the extraction of pharmaceutically active components from plant materials. | |
ATE321537T1 (en) | PHARMACEUTICAL PREPARATION CONTAINING DOXAZOSINE | |
GB0107106D0 (en) | Powder inhaler formulations | |
NZ603744A (en) | Balsalazide formulations and manufacture and use thereof | |
CR8371A (en) | DRUG FORMULATIONS CONTAINING FLAVORS WITH BETTER PHARMACEUTICAL PROPERTIES | |
IL166269A0 (en) | A pharmaceutical composition containing an activated form of diluted antibodies to ?-tnf | |
TR201910393T4 (en) | Mouthpiece for an inhaler. | |
EA201000677A1 (en) | DRY POWDERED COMPOSITIONS CONTAINING DERIVATIVES OF ASCORBIC ACID | |
EA200701805A1 (en) | COMPOSITION OF AEROSOL FOR DOSING INHALERS UNDER PRESSURE | |
RS50923B (en) | Aerosol formulation for inhalation comprising tiotropiumbromide | |
EA200500387A1 (en) | COMPOSITIONS FOR INHALATION WITH HIGH CONTENT OF MEDICINAL SUBSTANCES | |
ITMI20022549A1 (en) | QUATERNARY COMPOSITION INCLUDING PROPOLIS AS AN ACTIVE SUBSTANCE. | |
UY27314A1 (en) | INHALATION CAPSULES | |
AR064046A1 (en) | DUST INHALERS | |
GB0417909D0 (en) | Drop preparations |